Imaging Biomarkers of Progression of Mobility Impairment in Parkinson Disease

NCT01106976 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 67

Last updated 2016-02-01

Study results available
· View outcomes & findings →

Summary

The purpose of this research is to evaluate changes in cholinergic brain activity over time in subjects with Parkinson disease.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Nicolaas I Bohnen, MD PhD · VA Ann Arbor Healthcare System, Ann Arbor, MI

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-05-31
Primary Completion
2014-09-30
Completion
2015-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01106976 on ClinicalTrials.gov